Baxter To Resume U.S. Distribution Of Nexell Cell Processing Systems
This article was originally published in The Gray Sheet
Executive Summary
Baxter will resume full distribution responsibilities for Nexell Therapeutic's Isolex 300i magnetic cell selection system as part of a Nexell effort to move out of the device business in favor of biological therapeutics.